Pancreatic Polypeptide, ECL

Test Code

39438

CPT Codes
83520

Preferred Specimen

0.5 mL plasma collected in an EDTA (lavender-top) tube

Patient Preparation
Overnight fasting is preferred

Minimum Volume

0.3 mL

Instructions

Draw blood in an EDTA (lavender-top) tube. Centrifuge and separate plasma from cells.

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 5 days
Refrigerated: 7 days
Frozen: 1 year

Methodology
Electrochemiluminescence (ECLIA)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

A.M. Sets up 1 day a week.

Report Available

Reports in 4 to 8 days.

Clinical Significance

Detection of Pancreatic Polypeptide is used in the assessment of pancreatic tumor burden and to assist in the early diagnosis of pancreatic endocrine tumors. The measurement of pancreatic polypeptide is also used to monitor pancreatic carcinoma therapy and to predict the recurrence of pancreatic tumors.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.